By Maggie Fick

VIENNA (Reuters) -Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, according to two sources close to the company and LinkedIn posts reviewed by Reuters, an early sign of the drugmaker’s push to cut costs and regain ground on rival Eli Lilly.

The team, known internally as cardiometabolic educators, sat within Novo Nordisk’s commercial division and included several hundred staff, sources said. The team was told last week that their roles would be terminated, they said.

The specific layoffs, previously unreported, give the first signal of how the Danish drugmaker’s new CEO Maziar Mike Doustdar is scaling back operations after announcing broader restructuring that will include 9,000 job cuts globally.

A N

See Full Page